
Reversible ventricular arrythmia induced by dasatinib
Author(s) -
Spechbach Hervé,
Morel Philippe,
Lorenzini Kuntheavy Ing,
Besson Marie,
Gétaz Laurent,
Sunthorn Henri,
Chalandon Yves
Publication year - 2013
Publication title -
clinical case reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.21
H-Index - 9
ISSN - 2050-0904
DOI - 10.1002/ccr3.5
Subject(s) - medicine , dasatinib , cardiology , ejection fraction , sudden cardiac death , heart failure , sudden death , qt interval , myeloid leukemia , imatinib
Key Clinical Message Ventricular arrhythmias induced by dasatinib are rare events, but physicians in charge of chronic myeloid leukemia patients should be aware of such potential complications and the need for regular ECG controls during treatment with tyrosine kinase inhibitors.